Cardioprotection of cancer patients receiving cardiotoxic chemotherapy — current status
Certain drugs used for the treatment of cancer can have a toxic effect on various organs and tissues, including the heart. Not only high-dose monotherapy can lead to damage to the heart muscle, but also a combination of two or three chemotherapy drugs can do so. Cancer patients receiving combination...
Main Authors: | Anton K. Peresada, David P. Dundua, Anna G. Kedrova, Irina N. Oleynikova, Anna V. Masterkova |
---|---|
Format: | Article |
Language: | English |
Published: |
Eco-vector
2024-01-01
|
Series: | Клиническая практика |
Subjects: | |
Online Access: | https://journals.eco-vector.com/clinpractice/article/viewFile/567924/pdf |
Similar Items
-
The use of sodium-glucose cotransporter type 2 inhibitors for the purpose of treating the chronic cardiac failure in oncology patients receiving cardiotoxic chemotherapy: preliminary results
by: Anton K. Peresada, et al.
Published: (2024-11-01) -
The use of quadrotherapy of chronic heart failure in cancer patients (case series)
by: Anton K. Peresada, et al.
Published: (2023-07-01) -
A review of cardioprotective effect of ginsenosides in chemotherapy-induced cardiotoxicity
by: Hadi Zare-Zardini, et al.
Published: (2024-12-01) -
Nuclear imaging of chemotherapy-induced cardiotoxicity
by: A. A. Ansheles, et al.
Published: (2021-03-01) -
Cardioprotection From Cardiotoxicity
by: Guilherme H. Oliveira, MD, MBA
Published: (2019-09-01)